Condition
PARKINSON DISEASE (Disorder) clinical trials and research
Research outlook What's coming for Parkinson's disease: the next 6 months to 5 yearsAs of November 12, 2026, Find a Trial lists 48 PARKINSON DISEASE (Disorder) clinical trials that are recruiting, at sites in 21 countries (most in United States (14), Italy (7), Spain (4)). 2 were first registered in the last 30 days. By phase: Phase 1 (3), Phase 3 (2), Phase 1/2 (2), Phase 2 (2). The most active sponsors are CND Life Sciences (2), Kahramanmaras Sutcu Imam University (2), University of Alabama at Birmingham (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 48Clinical trials
- 2New in 30 days
- 21Countries
Newest PARKINSON DISEASE (Disorder) clinical trials
All recruiting trials (48)
-
UX-DA003 injections for Parkinson's disease
This early-phase trial tests whether injecting UX-DA003 is safe and may help motor symptoms in people with Parkinson's whose response to standard treatments has declined.
-
Strength and dual-task training to help people with Parkinson’s improve strength and function
This trial tests three levels of physiotherapy, including progressive resistance training with and without cognitive dual-task and instability components, to see if they improve muscle strength, body composition, and physical function in adults with Parkinson’s or related syndromes.
-
Spinal Mobility, Rigidity, and Kinesiophobia in Parkinson's Disease with and without TMD
This study tests whether people with Parkinson's disease who have Temporomandibular Disorders differ in spinal mobility, axial rigidity, and kinesiophobia from those without TMD.
-
A 12-Week Trial of Flexilev with the OraFID Device and App for Parkinson's
This study tests whether taking small, precise doses of Flexilev with the OraFID dosing device and Levilog app is acceptable and helps people with Parkinson's manage their medicine.
-
Integrated Motor-Cognitive Training in Parkinson's Disease
This study tests a combined motor and cognitive rehabilitation program to see if people with Parkinson’s disease can stick with it and show early signs of benefit.
-
VIM0423 for Parkinson's Tremor in Adults Not Fully Controlled by Dopaminergic Therapy
A Vima Therapeutics study tests whether the oral drug VIM0423 can reduce tremor in adults with Parkinson’s disease who still have tremor despite dopaminergic treatment.
-
Optimizing Adaptive Deep Brain Stimulation for Parkinson's Disease
This study tests whether using ongoing brain signals gathered during daily life can improve adaptive deep brain stimulation for people with Parkinson's who have motor fluctuations.
-
Wearable sensors to track tremor and daily movement in Parkinson’s disease and essential tremor
A wearable sensor study will test how tremor and upper-limb movement look in adults with Parkinson’s or essential tremor, using sensors worn at clinic and at home.
-
Gut methane and Parkinson's: measuring if a probiotic helps people with Parkinson's, REM sleep behavior disorder, or cognitive concerns
This study tests whether a probiotic containing Limosilactobacillus reuteri can help people with Parkinson's disease, those at high risk for PD, and related cognitive issues by potentially improving gut methane levels and overall symptoms.
-
Seeing how the Short Physical Performance Battery works for people with Parkinson's in Galicia
This study tests whether the Short Physical Performance Battery (SPPB) is reliable and valid for adults with Parkinson's disease living in Galicia, Spain.
-
Safinamide added to standard therapy for PD-related pain
This Phase 3 trial tests whether safinamide, added to usual Parkinson’s medication, reduces PD-related pain more than placebo in adults with motor fluctuations and chronic pain.
-
See if deep brain stimulation for Parkinson's changes thinking and movement and affects fall risk
This pilot study tests whether deep brain stimulation in people with Parkinson’s changes thinking or movement and whether those changes relate to how often they fall.
-
Early diagnosis of Parkinson's using digital and neurogenic exosome biomarkers
This study tests whether digital biomarkers from wearable devices and neurogenic exosome biomarkers in blood can help identify Parkinson's disease earlier, by comparing healthy individuals, people at prodromal risk, and those with early Parkinson's.
-
MF1: a first-in-human test in healthy men and people with Parkinson's disease
This early study tests MF1 to see if it is safe and how it behaves in the body, first in healthy Japanese men and then in people with Parkinson's disease- related symptoms.
-
Tai Chi vs Qi-Gong for early-stage Parkinson’s patients
A randomized study tests whether Tai Chi therapy or Qi-Gong can improve balance and motor function in people with early-stage Parkinson’s disease.
-
Feasibility of a community-based, personalized multimodal exercise program for Parkinson's disease
A 12-week, group-based but individually tailored exercise program is being tested in people with Parkinson's to see if it can be feasibly delivered in a community setting and whether it shows preliminary benefits.
-
Tracking physical activity changes in people with Parkinson's
This project will follow about 450 people with Parkinson's over four years using wearable activity monitors, clinical tests, and questionnaires to see which physical, cognitive, social, or environmental factors make people less active.
-
Gut-brain in PD Consortium: understanding gut influences in Parkinson's and prodromal stages
This study tests how the gut and brain communicate in people with Parkinson's, those without PD, and those at risk, to see if gut factors relate to disease onset and progression.
-
Ear vagus nerve stimulation to improve heart rate and blood pressure control in Parkinson's disease
This study will see if gentle ear-based vagus nerve stimulation can help people with Parkinson's disease better control their heart rate and blood pressure.
-
Accelerated rTMS for Motor and Thinking in Parkinson's
This pilot study tests whether a fast, intensive course of rTMS aimed at the motor cortex can help with movement and thinking abilities in adults with mild-to-moderate Parkinson's disease.
-
Independent walking program with or without walking poles for people with Parkinson disease
This study will test whether an 8-week independent walking program using walking poles helps people with Parkinson disease improve their walking compared with walking without poles.
-
Steady Together: a home fall-prevention program for people with Parkinson's
This program will try an occupational therapy–led home visit and online tools to reduce fall risk and increase safety confidence for people with Parkinson's who are InMotion members.
-
Home-based remote temporal interference stimulation for motor problems in Parkinson's disease
This trial will test whether daily, remotely supervised home temporal interference brain stimulation can help movement problems like slowness, stiffness, and walking difficulty in people with Parkinson's disease.
-
Aerobic training to improve brain blood flow, thinking, and walking in Parkinson's
This will test whether a 12-week supervised aerobic exercise program improves cerebral blood flow, cognition, and gait in people with Parkinson's disease (Hoehn & Yahr stages 1–3).
-
Precision medicine approach for diagnosing and treating Parkinson's, Alzheimer's, and type 2 diabetes
This project will test whether genetic, metabolic, epigenetic and brain-imaging patterns can help diagnose and guide care for people with Parkinson's disease, Alzheimer's disease, or type 2 diabetes.
-
IRL757 for treating apathy in Parkinson's disease.
This study will test whether the medication IRL757 is safe, easy to tolerate, and helps reduce apathy in people aged 50–90 with Parkinson's disease.
-
Understanding How Priors Influence Hallucinations in Parkinson’s
Researchers test whether expectations make people with Parkinson’s hallucinate more during a simple visual task than those without hallucinations.
-
Single-dose SER-252 treatment for people with Parkinson's disease and motor fluctuations
This study will try a single subcutaneous dose of SER-252 versus placebo in adults with Parkinson's disease who have motor fluctuations and at least 2 hours of daily OFF time.
-
Brain activity linked to motor and psychiatric ups and downs in Parkinson's
The study will see if EEG and recordings from patients' subthalamic deep brain stimulator can reveal brain signals tied to motor and psychiatric fluctuations in people with Parkinson's who are on dopaminergic therapy and recently had STN‑DBS.
-
EarStim for short- and long-term relief of Parkinson's motor symptoms
This study tests whether a wearable EarStim device can give intermittent short- and long-term relief of motor symptoms in adults with moderate-to-severe Parkinson's disease who experience wearing-off.
-
Robotic upper-limb therapy with built-in cognitive exercises for people with Parkinson's, MS, or stroke
This trial will test whether sensor-based robotic arm training that includes thinking exercises can help adults with Parkinson's disease, multiple sclerosis, or stroke improve attention, memory, and arm movement.
-
Blood-based predictors of DBS outcomes for Parkinson's disease
This project will test whether proteins and RNA in blood can predict how people with Parkinson's disease will respond to deep brain stimulation (DBS).
-
How walking skills transfer from split-belt treadmill to overground walking in Parkinson's
This project will test whether stimulating a brain area called the posterior parietal cortex with repeated TMS helps people with Parkinson's transfer improvements from split-belt treadmill training to normal overground walking.
-
Italian version of the GIDS-PD (Gastrointestinal Dysfunction Scale for Parkinson's disease)
This project will test an Italian translation of the Gastrointestinal Dysfunction Scale for people with Parkinson's disease to help measure stomach and bowel symptoms.
-
Daily transcranial pulsed electromagnetic field (T-PEMF) therapy for Parkinson's disease
This trial tests whether daily 30-minute sessions of transcranial pulsed electromagnetic fields (T-PEMF) help people with early-stage Parkinson's disease.
-
Whole-body light therapy for motor and thinking symptoms in Parkinson's disease
This trial will test whether about 10 weeks of whole-body photobiomodulation (20 minutes per session, about three times a week) can improve movement and thinking in adults with Parkinson's disease who can walk independently.
-
Vagus nerve stimulation to improve ankle muscle activity and posture in Parkinson's disease
This project will test whether non-invasive vagus nerve stimulation at the neck can improve ankle muscle activation, walking, and balance in people with Parkinson's disease.
-
Detecting Parkinson's-related alpha-synuclein in colon tissue taken during routine colonoscopy
This will see if small extra colon tissue samples taken during a routine colonoscopy can find phosphorylated alpha-synuclein in people with Parkinson's disease or REM sleep behavior disorder.
-
Detecting phosphorylated alpha-synuclein in colon tissue to help diagnose Parkinson's
This study will test whether routine colonoscopy tissue samples from adults with Parkinson's show phosphorylated alpha-synuclein, a protein linked to the disease.
-
Motor imagery training to improve hand dexterity and balance in Parkinson's disease
This program will test whether guided mental imagery exercises can help people aged 40–75 with Parkinson's disease improve hand dexterity and balance.
-
Mental imagery to improve arm and hand skills in Parkinson's
This trial will test whether guided mental imagery exercises can help people with Parkinson's improve arm and hand movement and dexterity.
-
Multicontext Approach to Help Daily Thinking in Parkinson’s
This study tests whether a Multicontext strategy training program can improve daily thinking and function for people with early Parkinson’s who notice cognitive changes.
-
At-home electrical brain stimulation for Parkinson's movement symptoms
This trial tests a wearable, at-home electrical stimulation device called Sphere V3.0 to see if it improves movement problems in adults with Parkinson's disease.
-
Intestinal levodopa plus entacapone (Lecigon®) to reduce dopaminergic desensitization and neuropsychiatric complications in Parkinson's
This trial will try intestinal levodopa plus entacapone (Lecigon®) versus best oral medication in people with Parkinson's who are eligible for Lecigon to see if it reduces hyperdopaminergic symptoms after six months.
-
Vitamin D3 and brain wave patterns in men with Parkinson's disease and low vitamin D
This will test whether taking a weekly high-dose vitamin D3 capsule for 8 weeks changes brain wave patterns in men with Parkinson's disease who have low vitamin D levels.
-
Group program to manage fatigue and boost energy-conservation confidence for people with Parkinson's disease
This trial will test whether a group-based fatigue management program helps people with Parkinson's disease feel more confident using energy-conservation strategies compared with receiving standard informational sheets.
-
Mediterranean diet for people with Parkinson's disease
This study will try a Mediterranean diet to see if it helps motor and non-motor symptoms in people with Parkinson's disease.
-
Probiotics for depression and mood problems in Parkinson's disease
This trial will test whether a 12-week oral multi-strain probiotic can improve depressive symptoms in people with Parkinson's disease.
Related topics
Quick answers
How many PARKINSON DISEASE (Disorder) clinical trials are recruiting right now?
48, as of November 12, 2026. 2 of them were first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 21 countries. The most sites are in United States (14 trials), Italy (7 trials), Spain (4 trials), Turkey (Türkiye) (4 trials), Canada (3 trials). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 3, Phase 3: 2, Phase 1/2: 2, Phase 2: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.